Inducibility of ethoxyresorufin deethylase and UDP-glucuronosyltransferase activities in two human hepatocarcinoma cell lines KYN-2 and Mz-Hep-1

被引:6
作者
Abid, A [1 ]
Sabolovic, N [1 ]
Magdalou, J [1 ]
机构
[1] UNIV NANCY 1,CTR MED,URA CNRS 597,F-54000 NANCY,FRANCE
关键词
cytochrome P450; human hepatoma cell lines; inducibility; UDP-glucuronosyltransferase;
D O I
10.1007/BF00143361
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Two human hepatoma cell. lines, KYN-2 and Mz-Hep-1 were characterized in terms of glucuronidation capacity and inducibility of cytochrome P4501A1/1A2 and several UDP-glucuronosyl-transferases (UGTs). Cytochrome P4501A1/1A2 activity was measured using 7-ethoxyresorufin and that of UGTs with 16 different substrates. The effects of dimethyl sulfoxide (DMSO), beta-naphthoflavone, alpha-naphthoflavone, and rifampicin on these drug-metabolizing enzyme activities were studied. DMSO treatment increased in a dose-dependent manner the ethoxyresorufin O-deethylase (EROD) activity in KYN-2 cells, while an opposite effect was observed in Mz-Hep-1 cells. In KYN-2 cells, EROD was more responsive toward beta-naphthoflavone treatment in combination with DMSO. This activity was enhanced in Mz-Hep-1 cells more than 83 times by beta-naphthoflavone. The enhancement of EROD activity by DMSO and beta-naphthoflavone treatments of KYN-2 cells was abolished by alpha-naphthoflavone treatment. In Mz-Hep-1, only the inducing effect of beta-naphthoflavone was abolished by alpha-naphthoflavone treatment. Rifampicin treatment of KYN-2 cells reversed both the DMSO and beta-naphthoflavone effects on the EROD activity. Glucuronidation of steroids, bile acids, fatty acids and drugs was effective in KYN-2 and Mz-Hep-1 cells. Both 1-naphthol glucuronidation and the level of UGT1*6 protein detected by immunoblot and supporting this activity were lowered by DMSO treatment and increased by beta-naphthoflavone treatment in KYN-2 cells. In Mz-Hep-1 cells, DMSO and beta-naphthoflavone had no effect on 1-naphthol glucuronidation activity. DMSO, beta-naphthoflavone and rifampicin also affected the glucuronidation of various substrates supported by different UGT isoforms. These results indicate that KYN-2 and Mz-Hep-1 cells can be used as new in vitro models for the studies of drug metabolism and the regulation of the corresponding enzymes.
引用
收藏
页码:115 / 123
页数:9
相关论文
共 26 条
[1]  
Abid A., 1994, Cellular Pharmacology, V1, P257
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   THE UDP GLUCURONOSYLTRANSFERASE GENE SUPERFAMILY - SUGGESTED NOMENCLATURE BASED ON EVOLUTIONARY DIVERGENCE [J].
BURCHELL, B ;
NEBERT, DW ;
NELSON, DR ;
BOCK, KW ;
IYANAGI, T ;
JANSEN, PLM ;
LANCET, D ;
MULDER, GJ ;
CHOWDHURY, JR ;
SIEST, G ;
TEPHLY, TR ;
MACKENZIE, PI .
DNA AND CELL BIOLOGY, 1991, 10 (07) :487-494
[4]   EXPRESSION OF SPECIFIC UDP-GLUCURONOSYLTRANSFERASE ISOFORMS IN CARCINOGEN-INDUCED PRENEOPLASTIC RAT-LIVER NODULES [J].
CHOWDHURY, NR ;
SABER, MA ;
LAHIRI, P ;
MACKENZIE, PI ;
NOVIKOFF, PM ;
BECKER, FF ;
CHOWDHURY, JR .
HEPATOLOGY, 1991, 13 (01) :38-46
[5]  
DIPPOLD WG, 1985, HEPATOLOGY, V6, P1112
[6]   PROPERTIES OF HUMAN HEPATIC UDP-GLUCURONOSYLTRANSFERASES - RELATIONSHIP TO OTHER INDUCIBLE ENZYMES IN PATIENTS WITH CHOLESTASIS [J].
DRAGACCI, S ;
THOMASSIN, J ;
MAGDALOU, J ;
ELAMRI, HS ;
BOISSEL, P ;
SIEST, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (05) :485-491
[7]  
DRAGACCI S, 1988, CELLULAR MOL ASPECTS, V730, P249
[8]  
EBNER T, 1993, DRUG METAB DISPOS, V21, P50
[9]   SUBSTRATE-SELECTIVE INDUCTION OF RABBIT HEPATIC UDP-GLUCURONYLTRANSFERASES BY ETHANOL AND OTHER XENOBIOTICS [J].
FINLEY, BL ;
ASHLEY, PJ ;
NEPTUNE, AG ;
YOST, GS .
BIOCHEMICAL PHARMACOLOGY, 1986, 35 (17) :2875-2881
[10]  
FOURNELGIGLEUX S, 1991, MOL PHARMACOL, V39, P177